about
Management of a vertically transmitted neonatal Chikungunya thrombocytopenia.Working towards dengue as a vaccine-preventable disease: challenges and opportunities.Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli.Detection of dengue virus.Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice.Development of a pilot-scale production process and characterization of a recombinant Japanese encephalitis virus envelope domain III protein expressed in Escherichia coli.Enhanced production and immunological characterization of recombinant West Nile virus envelope domain III protein.
P50
Q33394195-13A64A77-2078-4E80-A559-0FB3D5D9DA0CQ38657783-E8E1286E-FE72-497C-9BF9-5BB285CF62CCQ40326193-54A83C17-6AE5-48F7-A8C2-F5556078F86BQ40342173-3FE44FAC-9C40-42D6-B183-9D68F0427ADDQ40413896-852411A6-D2E1-4F02-BC79-5575E7DC0EA4Q42980135-02DC5BC9-2202-4F71-B288-05DB1E92A4B2Q54210121-06140EBA-B004-4281-8573-EBD81E60C9E1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ambuj Shrivastava
@ast
Ambuj Shrivastava
@en
Ambuj Shrivastava
@es
Ambuj Shrivastava
@nl
Ambuj Shrivastava
@sl
type
label
Ambuj Shrivastava
@ast
Ambuj Shrivastava
@en
Ambuj Shrivastava
@es
Ambuj Shrivastava
@nl
Ambuj Shrivastava
@sl
prefLabel
Ambuj Shrivastava
@ast
Ambuj Shrivastava
@en
Ambuj Shrivastava
@es
Ambuj Shrivastava
@nl
Ambuj Shrivastava
@sl
P106
P1153
23978922200
P31
P496
0000-0003-1735-4692